Contraceptive Technology Update – October 1, 2018
October 1, 2018
View Issues
-
New Contraceptive Ring Option Receives FDA Approval
Annovera, a soft, reusable, flexible silicone ring containing segesterone acetate and ethinyl estradiol, has been approved by the U.S. Food and Drug Administration.
-
Company to Halt U.S. Sales of Essure Device
International pharmaceutical company Bayer has announced that it will cease U.S. sales of its Essure sterilization device as of December 2018. Although the company is halting distribution because of declining sales, the decision comes amid mounting concerns surrounding its use.
-
Options Considered for Access to Medication Abortion
As restrictions of clinic access to abortion mount, some women may seek internet access to services. Research indicates that women seeking medication abortion drugs online choose to do so because of barriers to clinic access in states with and without restrictive abortion laws. The choice also can happen when women prefer to self-manage their abortion rather than receive clinical care.
-
Researchers Examine Postmenopausal Bleeding and Endometrial Cancer
To inform clinical decision-making, investigators performed an analysis looking at the frequency of postmenopausal bleeding in endometrial cancers and the risk of endometrial cancer among women who have postmenopausal bleeding.
-
Gynecologic Cancers Detected Earlier Because of Affordable Care Act
The diagnosis of gynecologic cancers in young women is occurring at earlier stages because of implementation of the Affordable Care Act, according to results of a recent analysis.
-
New Recommendations Focus on HIV Antiretrovirals
Clinicians involved in preventing and treating HIV will want to update their knowledge base with recommendations from the International Antiviral Society–USA for the use of antiretroviral drugs.